[1] Riva F,Bonavita E,Barbati E,et al.TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor family member with regulatory functions in inflammation and immunity[J].Front Immunol,2012,3:322.
[2] Laukoetter M G,Nava P,Nusrat A.Role of the intestinal barrier in inflammatory bowel disease[J].World J Gastroenterol,2008,14(3):401-407.
[3] Säemann M D,Weichhart T,Zeyda M,et al.Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism[J].J Clin Invest,2005,115(7):468-475.
[4] Sobek V,Birkner N,Falk I,et al.Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease[J].Arthritis Res Ther,2004,6(5):433-446.
[5] Biragyn A,Ruffini P A,Leifer C A,et al.Toll-like receptor 4-dependent activation of dendritic cells by bate-defensin[J].Science,2002,298(5595):1025-1029.
[6] 陈旭昕,钱桂生.SIGIRR与TLRs信号通路[J].四川医学,2011,3:428-430.
[7] Garlanda C,Di Liberto D,Vecchi A,et al.Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8/single Ig IL-1-related receptor,a negative regulator of IL-1/TLR signaling[J].The Journal of Immunology,2007,179(5):3119-3125.
[8] 黄勋,姜涛.SIGIRR在固有免疫中的负性调节作用[J].现代医药卫生,2011,5:710-712.
[9] Riva F,Polentarutti N,Tribbioli G,et al.The expression pattern of TIR8 is conserved among vertebrates[J].Vet Immunol and Immunopathol,2009,131(1-2):44-49.
[10] Thomassen E,Renshaw B R,Sims J E.Identification and characterization of SIGIRR,a molecule representing a novel subtype of the IL-1R superfamily[J].Cytokine,1999,11(6):389-399.
[11] Wald D,Qin J,Zhao Z,et al.SIGIRR,a negative regulator of Toll-like receptor-interleukin 1 receptor signaling[J].Nat Immunol,2003,4(9):920-927.
[12] Garlanda C,Anders H J,Mantovani A.TIR8/SIGIRR:An IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization[J].Trends Immunol,2009,30(9):439-446.
[13] Riva F,Rahman M M,Turin L,et al.TIR8 receptor expression in bovine tissues[J].Vet Immunol and Immunopathol,2010,136(1):65-70.
[14] Xiao H,Gulen M F,Qin J,et al.The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis,inflammation,and tumorigenesis[J]. Immunity,2007,26(4):461-475.
[15] Polentarutti N,Rol G P,Muzio M,et al.Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR[J].European Cytokine Network,2003,14(4):211-218.
[16] Turin L,Manarolla G,Rampin T,et al.The innate immunity receptor TIR8/SIGIRR is expressed in the early developmental stages of chicken embryos[J].J Biol Regul Homeost Agents,2013,28(1):33-40.
[17] Turin L,Manarolla G,Riva F.Expression of TIR8 receptor in chicken tissues[J].J Biol Regul Homeost Agents,2013,28(3):515-522.
[18] Lech M,Garlanda C,Mantovani A,et al.Different roles of TIR8/SIGIRR on Toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells[J]. Kidney International,2007,72(2):182-192.
[19] Garlanda C,Riva F,Polentarutti N,et al.Intestinal inflammation in mice deficient in TIR8,an inhibitory member of the IL-1 receptor family[J]. Proc Natl Acad Sci USA,2004,101(10):3522-3526.
[20] Adib C M,Adrie C,Fitting C,et al.Up-regulation of MyD88s and SIGIRR,molecules inhibiting Toll-like receptor signaling,in monocytes from septic patients[J].Crit Care Med,2006,34(9):2377-2385.
[21] Daniels M A,Hogquist K A,Jameson S C.Sweet‘n'sour:The impact of differential glycosylation on T cell responses[J]. Nat Immunol,2002,3(10):903-910.
[22] Christensen L L,Jensen U B,Bross P,et al.The C-terminal N-glycosylation sites of the human 1,3/4-fucosyltransferase Ⅲ,-Ⅴ,and-Ⅵ (hFucTⅢ,-Ⅴ and-Ⅵ) are necessary for the expression of full enzyme activity[J].Glycobiology,2000,10(9):931-939.
[23] 黄庆伦.TLR/NF-κB信号通路与其负性调控因子SIGIRR和IBD的关系[D].南昌:南昌大学,2008.
[24] Gong J,Wei T,Stark R W,et al.Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR:A computational approach[J].Journal of Structural Biology,2010,169(3):323-330.
[25] Nold-Petry C A,Lo C Y,Rudloff I,et al.IL-37 requires the receptors IL-18Rα and IL-1R8(SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction[J]. Nat Immunol,2015,16(4):354-365.
[26] Costelloe C,Watson M,Murphy A,et al.IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8[J].J Neurochem,2008,105(5):1960-1969.
[27] Barksby H E,Lea S R,Preshaw P M,et al.The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders[J].Clin Exp Immunol,2007,149(2):217-225.
[28] Dunn E F,Gay N J,Bristow A F,et al.High-resolution structure of murine interleukin-1 homologue IL-1F5 reveals unique loop conformations for receptor binding specificity[J]. Biochemistry,2003,42(37):10938-10944.
[29] 严红.SIGIRR和IL-1F5对肠上皮细胞TLR/IL-1信号传导通路的作用机制[D].南昌:南昌大学,2010.
[30] Li X,Qin J.Modulation of Toll-interleukin 1 receptor mediated signaling[J]. J Mol Med,2005,83(4):258-266.
[31] 蒋克国,王德光,周海胜,等.稳定敲低SIGIRR的人肾小管上皮细胞的构建及其初步功能的研究[J].安徽医科大学学报,2015,2:129-135.
[32] 张斌,白亢亢,卞尧尧,等.骨癌痛大鼠髓内SIGIRR的表达变化[J].免疫学杂志,2014,5:402-406.
[33] Watson M B,Costello D A,Carney D G,et al.SIGIRR modulates the inflammatory response in the brain[J].Brain Behav Immun,2010,24(6):985-995.
[34] Sham H P,Yu E Y,Gulen M F,et al.SIGIRR,a negative regulator of TLR/IL-1R signalling promotes microbiota dependent resistance to colonization by enteric bacterial pathogens[J]. PLoS Pathog,2013,9(8):e1003539.
[35] Zhang C,Wu X,Zhao Y,et al.SIGIRR inhibits toll-like receptor 4,5,9-mediated immune responses in human airway epithelial cells[J]. Molecular Biology Reports,2011,38(1):601-609.
[36] Qin J,Qian Y,Yao J,et al.SIGIRR inhibits interleukin-1 receptor-and toll-like receptor 4-mediated signaling through different mechanisms[J].Biol Chem,2005,280(26):25233-25241.
[37] Noris M,Cassis P,Azzollini N,et al.The Toll-IL-1R member TIR8/SIGIRR negatively regulates adaptive immunity against kidney grafts[J].The Journal of Immunology,2009,183(7):4249-4260.
[38] Li D,Zhang X,Chen B.SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells[J]. BMC Immunology,2015,16(1):1-11.
[39] Ueno-Shuto K,Kato K,Tasaki Y,et al.Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1(Sp1) via the toll-like receptor 4(TLR4)-p38 pathway in monocytes and neutrophils[J].Journal of Biological Chemistry,2014,289(26):18097-18109.
[40] Costello D A,Carney D G,Lynch M A.α-TLR2 antibody attenuates the Aβ-mediated inflammatory response in icroglia through enhanced expression of SIGIRR[J].Brain Behav Immun,2015,46:70-79.
[41] Nakashima H,Akahoshi M,Masutani K.Th1/Th2 balance of SLE patients with lupus nephritis[J]. Rinsho Byori,2006,54(7):706-713.
[42] Shah K,Lee W W,Lee S H,et al.Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus[J].Arthritis Res Ther,2010,12(2):402.
[43] Pernis A B.Th17 cells in rheumatoid arthritis and systemic lupus erythematosus[J].J Intern Med,2009,265(6):644-652.
[44] Bulek K,Swaidani S,Qin J,et al.The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response[J].J Immunol,2009,182(5):2601-2609.
[45] Bozza S,Zelante T,Moretti S,et al.Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection[J].J Immunol,2008,180(6):4022-4031.
[46] Wang D Y,Su C,Chen G M,et al.The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity[J].Mol Biol Rep,2015,42(2):423-430.
[47] Lech M,Kulkarni O P,Pfeiffer S,et al.TIR8/SIGIRR prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens[J]. J Exp Med,2008,205(8):1879-1888.
[48] Michelsen K S,Arditi M.Toll-like receptors and innate immunity in gut homeostasis and pathology[J].Curr Opin Hematol,2007,14(1):48-54.
[49] Trinchieri G,Sher A.Cooperation of Toll-like receptor signals in innate immune defence[J].Nat Rev Immunol,2007,7(3):179-190.
[50] Miyake K.Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors[J]. Semin Immunol,2007,19(1):3-10.
[51] Kawai T,Akira S.TLR signaling[C].Semin Immunol,2007,19(1):24-32.
[52] Ewaschuk J B,Dieleman L A.Probiotics and prebiotics in chronic inflammatory bowel diseases[J]. World J Gastroenterol,2006,12(37):5941-5950.
[53] Yamamoto-Furusho J K,Podolsky D K.Innate immunity in inflammatory bowel disease[J]. World J Gastroenterol, 2007,13(42):5577-5580.
[54] Lakatos P,Fischer S,Lakatos L,et al.Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors:Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "Toll"[J].World J Gastroenterol,2006,12(12):1829-1841.
[55] Garlanda C,Riva F,Polentarutti N,et al.Intestinal inflammation in mice deficient in TIR8,an inhibitory member of the IL-1 receptor family[J]. Proc Natl Acad Sci USA,2004,101(10):3522-3526.
[56] O'Neill L A.SIGIRR puts the brakes on Toll-like receptors[J].Nat Immunol,2003,4(9):823-824.
[57] 丁燕,南娟,刘谦.慢性炎症,肿瘤微环境与癌变[J].中国肺癌杂志,2009,12(9):1022-1031.
[58] 刘真,肖斌,毛旭虎,等.炎症与肿瘤的关系研究进展[J].现代生物医学进展,2009,9(3):591-594.
[59] Greten F R,Eckmann L,Greten T F,et al.IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer[J].Cell,2004,118(3):285-296.
[60] Huang B,Zhao J,Li H,et al.Toll-like receptors on tumor cells facilitate evasion of immune surveillance[J].Cancer Res,2005,65(12):5009-5014.
[61] Xiao H,Yin W,Khan M A,et al.Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc min mice[J].Gastroenterology,2010,139(2):574-585.
[62] Zhao J,Bulek K,Gulen M F,et al.Human colon tumors express a dominant-negative form of SIGIRR that promotes inflammation and colitis-associated colon cancer in mice[J].Gastroenterology,2015,149(7):1860-1871.
[63] Huang X,Hazlett L D,Du W,et al.SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling[J].J Immunol,2006,177(1):548-556. |